Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Bethlehem › NPI 1013933175
Hospital

ST Lukes Hospital

ST Lukes Hospital was paid $20.74M by Medicaid between Jan 2018 and Dec 2024, across 326 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.

33Billing provider infoST LUKES HOSPITAL
BETHLEHEM, PA 18015
33aNPI1013933175assigned 07/14/2006
33bProvider typeChildren's Hospital
28Total paid$20.74M
24GClaims427,032
24DCodes billed326
24AFirst – last monthJan 2018 – Dec 2024

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WOLFE, SCOTT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,581$187K
20195,097$389K
202056,379$2.92M
2021184,078$7.64M
202258,962$3.65M
202367,776$3.40M
2024incomplete53,159$2.56M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 18% 26,573 25,576 $3.63M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 16,093 15,363 $2.48M
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 11% 63,539 16,510 $2.34M
G0378 Hospital observation service, per hour 11% 2,422 2,190 $2.32M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 5.6% 14,470 13,669 $1.16M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4.2% 11,369 11,024 $879K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.0% 4,959 4,675 $821K
X0621 3.7% 3,466 2,384 $777K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2.4% 4,643 4,418 $492K
99050 2.0% 4,155 3,955 $412K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.5% 13,384 12,964 $315K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.5% 13,159 12,743 $308K
314 more codes
99203 Doctor's office visit, new patient (routine) 1.3% 2,509 $277K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 1.3% 6,074 $273K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 3,496 $196K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 6,431 $190K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,898 $170K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,684 $169K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 3,596 $141K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 887 $136K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 519 $122K
80053 Comprehensive metabolic panel <1% 12,541 $122K
78815 Positron emission tomography (PET) for limited area imaging <1% 139 $111K
80050 General health panel <1% 2,426 $105K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 1,005 $102K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,775 $101K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 369 $95K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 16,601 $78K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 10,394 $74K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 334 $74K
97162 <1% 946 $63K
X0616 <1% 337 $59K
80061 Lipid panel <1% 4,297 $57K
87070 <1% 6,457 $56K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 618 $53K
97161 <1% 770 $51K
X0620 <1% 283 $51K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 703 $51K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,478 $46K
99214 Doctor's office visit, returning patient (more involved) <1% 438 $46K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 165 $42K
84443 Thyroid stimulating hormone (TSH) <1% 2,110 $42K
77066 Tomosynthesis, mammo <1% 483 $40K
76642 <1% 1,010 $40K
76813 <1% 720 $38K
77067 Screening mammography, bilateral, including computer-aided detection <1% 442 $38K
70450 Computed tomography, head or brain; without contrast material <1% 732 $37K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,853 $37K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,638 $34K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 224 $32K
87631 <1% 238 $32K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 577 $30K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 465 $29K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,023 $28K
87150 <1% 656 $27K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 699 $25K
36415 Collection of venous blood by venipuncture <1% 3,849 $25K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 769 $25K
80048 Basic metabolic panel (calcium, ionized) <1% 3,130 $22K
300 Patient transfer system <300 <1% 456 $22K
95811 <1% 42 $21K
87480 <1% 894 $21K
87660 <1% 897 $21K
92567 <1% 1,642 $20K
80081 <1% 243 $20K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 460 $19K
86803 <1% 1,003 $19K
77065 Tomosynthesis, mammo <1% 280 $18K
70551 Magnetic resonance imaging, brain; without contrast material <1% 84 $17K
83036 Hemoglobin; glycosylated (A1C) <1% 2,540 $17K
87536 <1% 158 $17K
88341 <1% 264 $16K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,383 $16K
76801 <1% 389 $15K
95886 <1% 334 $15K
J1756 Injection, iron sucrose, 1 mg <1% 2,165 $15K
71275 Computed tomographic angiography, chest, with contrast material <1% 84 $14K
71046 Radiologic examination, chest; 2 views <1% 1,308 $14K
86480 <1% 203 $13K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 187 $13K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 745 $13K
81001 <1% 4,917 $13K
72082 <1% 325 $13K
88342 <1% 418 $13K
86003 <1% 102 $13K
88344 <1% 161 $13K
82728 <1% 1,089 $12K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 412 $12K
71250 <1% 223 $12K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 359 $12K
73610 <1% 648 $12K
72125 Computed tomography, cervical spine; without contrast material <1% 231 $12K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,163 $11K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 82 $11K
83970 <1% 284 $11K
82570 <1% 1,604 $11K
S9083 Global fee urgent care centers <1% 105 $11K
87510 <1% 724 $11K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 173 $11K
87186 <1% 1,262 $10K
93017 <1% 288 $10K
77063 Screening digital breast tomosynthesis, bilateral <1% 442 $10K
84439 <1% 1,300 $10K
92587 <1% 325 $9K
73110 <1% 653 $9K
97163 <1% 180 $9K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 232 $9K
87077 <1% 1,218 $9K
84702 <1% 558 $8K
19083 <1% 78 $8K
82607 <1% 785 $8K
85027 <1% 1,386 $8K
83540 <1% 951 $8K
82043 <1% 1,009 $8K
93971 <1% 149 $8K
76770 <1% 198 $8K
71045 Radiologic examination, chest; single view <1% 1,599 $7K
76536 <1% 154 $7K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 625 $7K
84484 <1% 1,105 $7K
70496 <1% 43 $7K
83690 <1% 1,508 $6K
70498 <1% 38 $6K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 312 $6K
92557 <1% 255 $6K
J3490 Unclassified drugs <1% 1,907 $6K
82784 <1% 372 $6K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 421 $6K
87340 <1% 427 $6K
97164 <1% 199 $6K
87653 <1% 147 $6K
73030 <1% 544 $6K
73562 <1% 401 $6K
73630 <1% 607 $5K
83735 <1% 861 $5K
86038 <1% 335 $5K
86255 <1% 310 $5K
94726 <1% 223 $5K
94729 <1% 203 $5K
84153 <1% 236 $5K
73560 <1% 382 $5K
97167 <1% 73 $5K
72141 <1% 24 $5K
72110 <1% 256 $5K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 30 $5K
84403 <1% 180 $4K
73130 <1% 473 $4K
73502 <1% 290 $4K
73564 <1% 311 $4K
96415 <1% 189 $4K
88313 <1% 85 $4K
90715 <1% 318 $4K
83550 <1% 850 $4K
93226 <1% 116 $4K
86618 <1% 171 $4K
84146 <1% 165 $4K
86850 <1% 558 $4K
72100 <1% 225 $4K
76818 <1% 54 $4K
81003 <1% 1,254 $4K
73590 <1% 236 $3K
96367 <1% 215 $3K
85610 <1% 1,155 $3K
95708 <1% 43 $3K
86235 <1% 106 $3K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 327 $3K
73221 <1% 12 $3K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 107 $3K
86361 <1% 102 $3K
86592 <1% 745 $3K
76819 Fetal biophysical profile; without non-stress testing <1% 54 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 57 $3K
84703 <1% 288 $3K
83655 <1% 255 $3K
82950 <1% 404 $3K
83880 <1% 124 $3K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 13 $3K
82746 <1% 255 $3K
85379 <1% 291 $2K
80076 <1% 307 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 86 $2K
87147 <1% 513 $2K
87205 <1% 520 $2K
76820 <1% 98 $2K
86140 <1% 802 $2K
97166 <1% 43 $2K
92556 <1% 131 $2K
OP250 <1% 1,259 $2K
93225 <1% 130 $2K
74018 <1% 163 $2K
84100 <1% 383 $2K
J2704 Injection, propofol, 10 mg <1% 7,132 $2K
87522 Neg quan hep c or qual rna <1% 48 $2K
93970 <1% 27 $2K
85652 <1% 688 $2K
86900 <1% 592 $2K
88142 <1% 117 $2K
86901 <1% 581 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 115 $2K
97597 <1% 155 $2K
76882 <1% 221 $2K
95911 <1% 29 $2K
86706 <1% 138 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 41 $2K
84156 <1% 449 $2K
83001 <1% 98 $2K
73080 <1% 156 $2K
82105 <1% 87 $2K
86800 <1% 95 $2K
86430 <1% 227 $2K
86704 <1% 104 $1K
84402 <1% 54 $1K
87255 <1% 35 $1K
92593 <1% 106 $1K
85730 <1% 287 $1K
J7030 Infusion, normal saline solution , 1000 cc <1% 763 $1K
73140 <1% 159 $1K
93923 <1% 39 $1K
94060 <1% 134 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,839 $1K
73552 <1% 72 $1K
83002 <1% 62 $1K
G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 13 $992.20
82550 <1% 181 $978.86
X0592 <1% 55 $965.70
70486 <1% 12 $917.76
96375 Therapeutic injection; each additional sequential IV push <1% 172 $906.47
92555 <1% 121 $901.29
99153 Mod sedat endo service >5yrs <1% 101 $897.96
95819 <1% 70 $868.42
82948 <1% 746 $865.97
85007 <1% 275 $860.96
81002 <1% 252 $823.54
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 13 $790.76
86705 <1% 56 $776.84
87081 <1% 139 $746.24
84550 <1% 139 $742.21
87430 <1% 85 $711.55
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 14 $707.20
72170 <1% 81 $691.10
84481 <1% 28 $657.50
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 5,356 $642.98
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 15 $620.46
72040 <1% 45 $617.35
86200 <1% 43 $567.97
87040 <1% 46 $557.20
84480 <1% 72 $556.23
86376 <1% 73 $548.06
82785 <1% 32 $526.12
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 155 $511.00
82248 <1% 81 $508.78
99152 <1% 99 $501.03
83605 <1% 92 $475.20
J2785 Injection, regadenoson, 0.1 mg <1% 13 $474.48
81025 <1% 370 $460.56
80164 <1% 25 $436.15
J7050 Infusion, normal saline solution, 250 cc <1% 918 $424.43
J1170 Injection, hydromorphone, up to 4 mg <1% 2,071 $403.87
G0109 Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes <1% 18 $371.81
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,199 $359.43
88304 <1% 64 $356.63
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,139 $352.99
73090 <1% 29 $337.33
95816 <1% 29 $330.26
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 43 $323.80
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 16 $301.83
72050 <1% 14 $287.87
87209 <1% 13 $276.85
82247 <1% 37 $259.21
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 32 $253.44
82947 <1% 82 $251.77
92552 <1% 29 $239.99
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,552 $236.29
84132 <1% 54 $212.67
86787 <1% 13 $206.59
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,889 $186.57
J2270 Injection, morphine sulfate, up to 10 mg <1% 491 $167.57
84425 <1% 26 $157.11
83615 <1% 29 $148.37
J3475 Injection, magnesium sulfate, per 500 mg <1% 641 $142.26
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,323 $141.86
84590 <1% 12 $137.80
82803 <1% 13 $137.52
86769 <1% 12 $136.96
94010 <1% 14 $128.42
87102 <1% 12 $128.04
85014 <1% 58 $121.85
J7120 Ringers lactate infusion, up to 1000 cc <1% 157 $118.16
83020 <1% 12 $116.60
82977 <1% 12 $116.05
76830 Ultrasound, transvaginal <1% 15 $109.60
87177 <1% 13 $103.35
A9585 Injection, gadobutrol, 0.1 ml <1% 56 $94.72
80178 <1% 14 $87.25
J0690 Injection, cefazolin sodium, 500 mg <1% 1,928 $78.65
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 111 $71.84
J1644 Injection, heparin sodium, per 1000 units <1% 707 $70.88
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,840 $58.40
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 43 $45.85
76937 <1% 12 $43.79
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 225 $42.26
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 410 $42.07
84295 <1% 14 $39.93
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 39 $38.35
82077 <1% 12 $21.06
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 33 $21.00
J2060 Injection, lorazepam, 2 mg <1% 138 $14.32
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 32 $10.62
J1630 Injection, haloperidol, up to 5 mg <1% 14 $8.90
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 481 $0.08
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 922 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 27 $0.00
81513 0% 40 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 18 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 64 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 154 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 14 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 241 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 73 $0.00
A9270 Non-covered item or service 0% 436 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 139 $0.00
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 0% 67 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 13 $0.00
J1836 Injection, metronidazole, 10 mg 0% 13 $0.00
C1769 Guide wire 0% 12 $0.00
94760 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWOLFE, SCOTT (SENIOR VP FINANCE)
Same official

Other billing entities under WOLFE, SCOTT

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.